Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. (CPH.TO) Revenue
Annual & quarterly revenue history · segment & region breakdown
CPH.TO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsCipher Pharmaceuticals Inc. trailing twelve-month (TTM) revenue is $0.05B, an increase of 53.87% year-over-year from $0.05B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.05B | +$0.02B | +53.87% |
| 2024-12-31 | $0.03B | +$0.01B | +57.66% |
| 2023-12-31 | $0.02B | +$0.00B | +2.36% |
| 2022-12-31 | $0.02B | -$0.00B | -5.78% |
| 2021-12-31 | $0.02B | +$0.00B | +1.56% |
| 2020-12-31 | $0.02B | -$0.00B | -3.76% |
| 2019-12-31 | $0.02B | -$0.00B | -1.31% |
| 2018-12-31 | $0.02B | -$0.02B | -43.58% |
| 2017-12-31 | $0.04B | -$0.00B | -1.03% |
| 2016-12-31 | $0.04B | +$0.01B | +18.40% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Cipher Pharmaceuticals Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Cipher Pharmaceuticals Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Cipher Pharmaceuticals Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CPH.TO revenue · 4 questionsCPH.TO's trailing twelve-month (TTM) revenue is $0.05B. That is an increase of 53.87% year-over-year from $0.05B in FY2025.
▸ Source: FMP · Cipher Pharmaceuticals Inc. SEC filings · GAAP · Cipher Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026